SCHEMBL27075633

SCHEMBL27075633

O=C(Nc1c(-c2ccncc2)[nH]c2cnccc12)c1cccc(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ CHUK O15111 5/20 0.52
▸ ICOSLG O75144 4/20 0.52
▸ ICOS Q9Y6W8 4/20 0.52
▸ IKBKB O14920 2/20 0.52
▸ PIM1 P11309 1/20 0.52
▸ PIM3 Q86V86 1/20 0.52
▸ IKBKG Q9Y6K9 1/20 0.52
▸ VSIG8 P0DPA2 1/20 0.46
▸ ROCK2 O75116 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MAPK3 P27361 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27075639 0.87 NT5E (0.54) MEN1KMT2ACHUKICOSLGICOS
SCHEMBL27075649 0.84 MEN1 (0.47) MEN1KMT2ACHUKICOSLGICOS
SCHEMBL27075643 0.78 BUB1 (0.52) MEN1KMT2ACHUKPIM1ROCK2
SCHEMBL27075654 0.76 MAPK1 (0.48) MEN1KMT2ACHUKROCK2NPC1
SCHEMBL27075652 0.72 BUB1 (0.46) MEN1KMT2AIKBKBSMN1; SMN2KDM4E
SCHEMBL16035183 0.71 SMN1; SMN2 (0.72) MEN1KMT2ASMN1; SMN2POLBTDP1
SCHEMBL14253079 0.69 CHUK (0.67) MEN1KMT2ACHUKICOSLGICOS
SCHEMBL29359984 0.68 CHUK (1.00) MEN1KMT2ACHUKICOSLGICOS
SCHEMBL1420453 0.68 CHUK (1.00) MEN1KMT2ACHUKICOSLGICOS
Hydrochloric Acid SCHEMBL12471533 0.67 CHUK (0.98) MEN1KMT2ACHUKICOSLGICOS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11891390-B1 3-substituted amino-2-arylpyrrolo[2,3-c]pyridines as CK2 inhibitors King Faisal University (SA) 2024-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11891390-B1 3-substituted amino-2-arylpyrrolo[2,3-c]pyridines as CK2 inhibitors CSNK2A3, CSNK2A2, CSNK2A1 MEN1 4829/4885KMT2A 1854/4885CHUK 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback